Vanda Pharmaceuticals IncNASDAQ:VNDA
- LAST PRICE5.1100
- TODAY'S CHANGE (%)0.1000 (1.9960%)
- Bid / Lots5.1100/ 2
- Ask / Lots5.2900/ 52
- Open / Previous Close5.0500 / 5.0100
- Day Range
- 52 Week Range
- Volume763,512
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VNDA |
|---|---|---|
| 09:32 ET | 12330 | 5.1039 |
| 09:34 ET | 682 | 5.09 |
| 09:36 ET | 14394 | 5.08 |
| 09:38 ET | 12322 | 5.14 |
| 09:39 ET | 22810 | 5.155 |
| 09:41 ET | 16663 | 5.13 |
| 09:43 ET | 2997 | 5.1005 |
| 09:45 ET | 1821 | 5.14 |
| 09:48 ET | 826 | 5.12 |
| 09:50 ET | 5657 | 5.11 |
| 09:52 ET | 46318 | 5.0898 |
| 09:54 ET | 14957 | 5.08 |
| 09:56 ET | 18372 | 5.061 |
| 09:57 ET | 20386 | 5.07 |
| 09:59 ET | 10178 | 5.1 |
| 10:01 ET | 600 | 5.08 |
| 10:03 ET | 5500 | 5.09 |
| 10:06 ET | 12800 | 5.0901 |
| 10:08 ET | 25431 | 5.095 |
| 10:10 ET | 14800 | 5.12 |
| 10:12 ET | 14127 | 5.15 |
| 10:14 ET | 4066 | 5.14 |
| 10:15 ET | 6600 | 5.13 |
| 10:17 ET | 3900 | 5.155 |
| 10:19 ET | 3806 | 5.165 |
| 10:21 ET | 1400 | 5.17 |
| 10:24 ET | 2048 | 5.17 |
| 10:26 ET | 5050 | 5.145 |
| 10:28 ET | 700 | 5.15 |
| 10:30 ET | 1200 | 5.13 |
| 10:32 ET | 843 | 5.12 |
| 10:33 ET | 1900 | 5.1189 |
| 10:35 ET | 3309 | 5.1 |
| 10:37 ET | 1884 | 5.085 |
| 10:39 ET | 1229 | 5.1 |
| 10:42 ET | 698 | 5.11 |
| 10:44 ET | 1300 | 5.1 |
| 10:46 ET | 1000 | 5.1091 |
| 10:48 ET | 694 | 5.1 |
| 10:50 ET | 200 | 5.11 |
| 10:51 ET | 1700 | 5.11 |
| 10:53 ET | 1713 | 5.12 |
| 10:55 ET | 4319 | 5.135 |
| 10:57 ET | 950 | 5.14 |
| 11:00 ET | 1599 | 5.14 |
| 11:02 ET | 3783 | 5.14 |
| 11:04 ET | 1147 | 5.13 |
| 11:06 ET | 200 | 5.13 |
| 11:08 ET | 300 | 5.13 |
| 11:09 ET | 400 | 5.13 |
| 11:11 ET | 621 | 5.13 |
| 11:13 ET | 200 | 5.13 |
| 11:15 ET | 200 | 5.14 |
| 11:18 ET | 100 | 5.14 |
| 11:20 ET | 1519 | 5.13 |
| 11:22 ET | 100 | 5.125 |
| 11:24 ET | 6787 | 5.13 |
| 11:26 ET | 500 | 5.14 |
| 11:27 ET | 1168 | 5.14 |
| 11:29 ET | 1321 | 5.15 |
| 11:31 ET | 300 | 5.145 |
| 11:33 ET | 200 | 5.155 |
| 11:36 ET | 200 | 5.15 |
| 11:38 ET | 1025 | 5.15 |
| 11:40 ET | 2487 | 5.135 |
| 11:42 ET | 298 | 5.14 |
| 11:44 ET | 1876 | 5.15 |
| 11:45 ET | 100 | 5.15 |
| 11:47 ET | 400 | 5.15 |
| 11:49 ET | 1600 | 5.155 |
| 11:51 ET | 400 | 5.15 |
| 11:54 ET | 100 | 5.1575 |
| 11:56 ET | 400 | 5.15 |
| 11:58 ET | 1398 | 5.155 |
| 12:00 ET | 5297 | 5.15 |
| 12:02 ET | 1996 | 5.13 |
| 12:03 ET | 200 | 5.13 |
| 12:05 ET | 100 | 5.13 |
| 12:07 ET | 300 | 5.125 |
| 12:09 ET | 4387 | 5.1201 |
| 12:12 ET | 1911 | 5.11 |
| 12:14 ET | 1522 | 5.11 |
| 12:16 ET | 200 | 5.12 |
| 12:18 ET | 100 | 5.12 |
| 12:20 ET | 1304 | 5.12 |
| 12:23 ET | 481 | 5.115 |
| 12:27 ET | 1223 | 5.1269 |
| 12:32 ET | 1447 | 5.105 |
| 12:34 ET | 2381 | 5.1 |
| 12:36 ET | 344 | 5.09 |
| 12:38 ET | 1100 | 5.085 |
| 12:39 ET | 200 | 5.08 |
| 12:41 ET | 450 | 5.0786 |
| 12:43 ET | 4380 | 5.0799 |
| 12:45 ET | 3800 | 5.08 |
| 12:48 ET | 1685 | 5.075 |
| 12:50 ET | 100 | 5.08 |
| 12:52 ET | 1600 | 5.08 |
| 12:54 ET | 2528 | 5.075 |
| 12:56 ET | 800 | 5.09 |
| 12:59 ET | 100 | 5.085 |
| 01:01 ET | 974 | 5.09 |
| 01:03 ET | 800 | 5.1 |
| 01:06 ET | 300 | 5.095 |
| 01:08 ET | 2238 | 5.095 |
| 01:10 ET | 100 | 5.095 |
| 01:12 ET | 500 | 5.095 |
| 01:15 ET | 2695 | 5.085 |
| 01:17 ET | 2029 | 5.0612 |
| 01:19 ET | 1387 | 5.08 |
| 01:21 ET | 1200 | 5.07 |
| 01:24 ET | 2454 | 5.065 |
| 01:26 ET | 811 | 5.08 |
| 01:28 ET | 600 | 5.09 |
| 01:30 ET | 200 | 5.09 |
| 01:32 ET | 200 | 5.085 |
| 01:33 ET | 100 | 5.085 |
| 01:35 ET | 100 | 5.085 |
| 01:37 ET | 100 | 5.085 |
| 01:42 ET | 1434 | 5.075 |
| 01:44 ET | 3999 | 5.0701 |
| 01:46 ET | 3846 | 5.0747 |
| 01:48 ET | 340 | 5.065 |
| 01:50 ET | 100 | 5.065 |
| 01:51 ET | 995 | 5.075 |
| 01:55 ET | 3300 | 5.075 |
| 01:57 ET | 249 | 5.065 |
| 02:00 ET | 1100 | 5.065 |
| 02:06 ET | 3800 | 5.065 |
| 02:08 ET | 200 | 5.065 |
| 02:09 ET | 100 | 5.07 |
| 02:13 ET | 2426 | 5.07 |
| 02:15 ET | 2118 | 5.0688 |
| 02:20 ET | 597 | 5.075 |
| 02:22 ET | 500 | 5.07 |
| 02:24 ET | 1000 | 5.075 |
| 02:29 ET | 200 | 5.075 |
| 02:31 ET | 4388 | 5.07 |
| 02:33 ET | 100 | 5.075 |
| 02:36 ET | 1200 | 5.07 |
| 02:38 ET | 2682 | 5.07 |
| 02:42 ET | 1000 | 5.075 |
| 02:44 ET | 3500 | 5.0701 |
| 02:51 ET | 1682 | 5.065 |
| 02:54 ET | 100 | 5.065 |
| 02:56 ET | 1180 | 5.07 |
| 03:00 ET | 3701 | 5.09 |
| 03:02 ET | 2400 | 5.09 |
| 03:03 ET | 10334 | 5.075 |
| 03:05 ET | 110 | 5.075 |
| 03:07 ET | 2106 | 5.0716 |
| 03:09 ET | 1784 | 5.08 |
| 03:12 ET | 663 | 5.08 |
| 03:14 ET | 500 | 5.08 |
| 03:16 ET | 2007 | 5.08 |
| 03:18 ET | 4681 | 5.1 |
| 03:20 ET | 1300 | 5.1078 |
| 03:21 ET | 4872 | 5.1 |
| 03:23 ET | 4248 | 5.1 |
| 03:27 ET | 437 | 5.11 |
| 03:30 ET | 634 | 5.105 |
| 03:32 ET | 250 | 5.11 |
| 03:34 ET | 475 | 5.11 |
| 03:36 ET | 698 | 5.11 |
| 03:38 ET | 1337 | 5.11 |
| 03:39 ET | 800 | 5.11 |
| 03:41 ET | 1008 | 5.11 |
| 03:43 ET | 1214 | 5.11 |
| 03:45 ET | 2208 | 5.12 |
| 03:48 ET | 3863 | 5.1111 |
| 03:50 ET | 5786 | 5.13 |
| 03:52 ET | 1910 | 5.13 |
| 03:54 ET | 1770 | 5.12 |
| 03:56 ET | 1000 | 5.115 |
| 03:57 ET | 701 | 5.11 |
| 03:59 ET | 6302 | 5.11 |
May 30, 2024
Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference, from 5:20PM ET on Thursday May 30, 2024 by Dow Jones
5:20PM ET on Thursday May 30, 2024 by Dow JonesVanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY(R), from 4:48PM ET on Thursday May 30, 2024 by Dow Jones
4:48PM ET on Thursday May 30, 2024 by Dow Jones
May 29, 2024
Vanda Pharmaceuticals Announces Presentations at SLEEP 2024, from 2:18PM ET on Wednesday May 29, 2024 by Dow Jones
2:18PM ET on Wednesday May 29, 2024 by Dow Jones
May 24, 2024
DJ Vanda Pharma Rejects Future Pak's Sweetened Takeover Bid, from 5:17PM ET on Friday May 24, 2024 by Dow Jones
5:17PM ET on Friday May 24, 2024 by Dow JonesPress Release: Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders, from 4:46PM ET on Friday May 24, 2024 by Dow Jones
4:46PM ET on Friday May 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vanda Pharmaceuticals Inc | 297.4M | -60.4x | -37.98% |
Akebia Therapeutics Inc | 234.7M | -5.1x | --- |
Anika Therapeutics Inc | 380.3M | -4.9x | --- |
Agenus Inc | 329.5M | -1.2x | --- |
Revance Therapeutics Inc | 296.6M | -0.8x | --- |
Sangamo Therapeutics Inc | 117.1M | -0.3x | --- |
Company Information
Vanda Pharmaceuticals Inc. is a biopharmaceutical company, which is focused on the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. The Company’s commercial portfolio is comprised of three products: HETLIOZ for the treatment of non-24-hour sleep-wake disorder (Non-24) and for the treatment of nighttime sleep disturbances in smith-magenis syndrome (SMS), Fanapt (iloperidone) for the treatment of bipolar I disorder and a long acting injectable (LAI) formulation for the treatment of schizophrenia, and PONVORY (ponesimod) for the treatment of inflammatory/autoimmune disorders, including ulcerative colitis, psoriasis, Crohn's disease, atopic dermatitis, eosinophilic esophagitis and alopecia areata. The Company also has a range of drugs in development, including Tradipitant (VLY-686), VHX-896, VSJ-110, VPO-227, VTR-297, VQW-765, VCA-894A and Type 2S (CMT2S).
Contact Information
- Headquarters
- SUITE 300E, 2200 PENNSYLVANIA AVE NWWASHINGTON, DC, United States 20037
- Phone
- 202-734-3400
- Fax
- 202-296-1450
Executives
- Chairman of the Board, President, Chief Executive Officer
- Mihael Polymeropoulos
- Chief Financial Officer, Senior Vice President, Treasurer
- Kevin Moran
- Senior Vice President, Chief Marketing Officer
- Joakim Wijkstrom
- Senior Vice President, General Counsel, Secretary
- Timothy Williams
- Senior Vice President - Business Development
- Gunther Birznieks
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $297.4M |
|---|---|
Revenue (TTM) | $177.6M |
Shares Outstanding | 58.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.71 |
EPS | $-0.08 |
Book Value | $9.47 |
P/E Ratio | -60.4x |
Price/Sales (TTM) | 1.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -14.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
